1-4 of 4
Gian-Paolo Rizzardi
Close
Sort by
Journal Articles

Chim3 confers survival advantage to CD4 + T cells upon HIV-1 infection by preventing HIV-1 DNA integration and HIV-1–induced G 2 cell-cycle delay

Simona Porcellini, Francesco Gubinelli, Luca Alberici, Bianca Maria Piovani, Gian-Paolo Rizzardi, Chiara Bovolenta
Journal: Blood
Blood (2010) 115 (20): 4021–4029.
https://doi.org/10.1182/blood-2009-09-243030
Published: 2010
Includes: Supplemental data
Journal Articles

NGR and isoDGR are separate moieties binding to different receptors

Gian-Paolo Rizzardi, Claudio Bordignon
Journal: Blood
Blood (2009) 113 (21): 5366.
https://doi.org/10.1182/blood-2009-02-207068
Published: 2009
Journal Articles

The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4 + T lymphocytes and CD34 + -derived macrophages by blocking HIV-1 DNA integration

Simona Porcellini, Luca Alberici, Francesco Gubinelli, Rossella Lupo, Clelia Olgiati, Gian-Paolo Rizzardi, Chiara Bovolenta
Journal: Blood
Blood (2009) 113 (15): 3443–3452.
https://doi.org/10.1182/blood-2008-06-158790
Published: 2009
Includes: Supplemental data
Journal Articles

Feasibility of a Stem Cell Gene Therapy Approach with Nonmyeloablative Conditioning in Patients with HIV-1 Infection.

Gian-Paolo Rizzardi, MD, Silvia Nozza, MD, Lucia Turchetto, PhD, Alexandre Harari, PhD, Giuseppe Tambussi, MD, Monica Salomoni, PhD, Fulvio Crippa, MD, Vega Rusconi, BSc, Salvatore Toma, PhD, Giuseppe Pantaleo, MD, Adriano Lazzarin, MD, Claudio Bordignon, MD
Journal: Blood
Blood (2004) 104 (11): 412.
https://doi.org/10.1182/blood.V104.11.412.412
Published: 2004